QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
QQQ   290.27 (-2.02%)
AAPL   143.00 (-2.01%)
MSFT   242.71 (-2.20%)
META   147.06 (-3.08%)
GOOGL   96.94 (-2.45%)
AMZN   100.55 (-1.65%)
TSLA   166.66 (-6.32%)
NVDA   191.62 (-5.91%)
NIO   12.02 (-5.43%)
BABA   111.20 (-6.07%)
AMD   72.45 (-3.91%)
T   20.16 (+1.05%)
MU   61.71 (-3.38%)
F   12.89 (-2.86%)
CGC   2.84 (-3.07%)
GE   80.83 (-2.88%)
DIS   107.59 (-1.78%)
AMC   5.01 (-9.07%)
PFE   43.55 (-0.55%)
PYPL   79.64 (-2.68%)
NFLX   353.11 (-2.12%)
LON:OPTI

OptiBiotix Health - OPTI Share Forecast, Price & News

GBX 13.50
0.00 (0.00%)
(As of 01/30/2023 12:00 AM ET)
Add
Compare
Today's Range
13.13
▼
13.50
50-Day Range
12.25
▼
21
52-Week Range
12.06
▼
46.40
Volume
11,226 shs
Average Volume
101,009 shs
Market Capitalization
£12.31 million
P/E Ratio
233.33
Dividend Yield
N/A
Price Target
N/A

OPTI stock logo

About OptiBiotix Health (LON:OPTI) Stock

OptiBiotix Health Plc, a life sciences company, engages in the research and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; WellBiome, a functional fibre and mineral blend that supports health & wellbeing by promoting the diversity of the gut microbiome; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia and lipid profiles, and diabetes. OptiBiotix Health Plc was founded in 2012 and is headquartered in York, the United Kingdom.

Receive OPTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter.

OPTI Stock News Headlines

January 15, 2023 | marketwatch.com
Home Meal Replacement (HMR) Market 2023 : Industry Analysis, Opportunities, Technology, Top Players and Growth Forecast 2028
December 5, 2022 | marketwatch.com
OptiBiotix Health Shares Fall on Discounted Fund Raising
January 30, 2023 | Investing Trends (Ad)
Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
October 24, 2022 | lse.co.uk
OptiBiotix Health gets approval to sell products in Saudi Arabia
August 30, 2022 | nz.finance.yahoo.com
Prebiotic Ingredients Market Size to Reach Around USD 20.78 Bn by 2030
August 24, 2022 | lse.co.uk
OptiBiotix shares plunge on "very difficult trading" in half-year
August 24, 2022 | marketwatch.com
OptiBiotix Health Sees 1H Sales Below Expectations; Shares Dive
August 23, 2022 | fool.co.uk
OptiBiotix Health
January 30, 2023 | Investing Trends (Ad)
Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
July 18, 2022 | benzinga.com
OptiBiotix Health (OTC:OPBXF), Earnings Estimates, EPS, and Revenue
July 18, 2022 | benzinga.com
OptiBiotix Health (OTC:OPBXF), Analyst Ratings, Price Targets, Predictions
July 11, 2022 | marketwatch.com
OptiBiotix Signs Selling, Manufacturing Joint Development Deal With Firmenich
June 28, 2022 | marketwatch.com
OptiBiotix 2021 Pretax Profit Rose on Higher Revenue; Says Making Good Progress in 2022
June 20, 2022 | lse.co.uk
OptiBiotix welcomes Steen Anderson as new CEO of ProBiotix spin-off
May 31, 2022 | lse.co.uk
Launch of cholesterol reducing yoghurt
April 21, 2022 | msn.com
PM Boris Johnson announces new deals worth £1bn on India visit
March 31, 2022 | proactiveinvestors.com
OptiBiotix Health CEO Stephen O’Hara explains why it makes sense to spin off ProBiotix Health
March 31, 2022 | proactiveinvestors.com.au
OptiBiotix Health demerger complete as ProBiotix Health debuts on Aquis exchange
February 28, 2022 | lse.co.uk
TRADING UPDATES: Profit rise for GlobalData, Greencoat keeps dividend
February 28, 2022 | marketwatch.com
OptiBiotix 2021 Sales, Gross Profit Rose as It Expanded to New Regions
February 9, 2022 | marketwatch.com
OptiBiotix Plans Territory, Product Line Expansions in 2022
January 30, 2022 | proactiveinvestors.com.au
Five at Five: Another FTSE 100 fall, rate rise coming, Optibiotix readies new generation of products, Biden turns on crypto and Tesla tanks
January 18, 2022 | proactiveinvestors.com
OptiBiotix Health says latest study supports case for LPLDL as an alternative to statins
January 11, 2022 | msn.com
SMALL CAP IDEAS: Biotech firm Optibiotix set to build on momentum with next gen microbiome-focused developments
January 11, 2022 | msn.com
SMALL CAP IDEAS: Biotech firm Optibiotix set to build on momentum
January 5, 2022 | lse.co.uk
OptiBiotix receives British Retail Consortium accreditation
December 1, 2021 | marketwatch.com
OptiBiotix Launches New Product, Signs License for GBP1 Mln a Year
See More Headlines
Receive OPTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter.

OPTI Company Calendar

Last Earnings
9/24/2020
Today
1/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
LON:OPTI
Previous Symbol
LON:CMI
CUSIP
N/A
CIK
N/A
Web
www.optibiotix.com
Phone
+44-20-79338780
Fax
N/A
Employees
8
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
233.33
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
4.51
Current Ratio
8.39
Quick Ratio
7.89

Sales & Book Value

Annual Sales
£1.26 million
Price / Sales
9.80
Cash Flow
GBX 1.56 per share
Price / Cash Flow
8.68
Book Value
GBX 24.70 per share
Price / Book
0.55

Miscellaneous

Outstanding Shares
91,191,000
Free Float
N/A
Market Cap
£12.31 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Stephen Patrick O'Hara
    Founder, CEO & Exec. Director
  • Dr. Sofia Kolyda (Age 50)
    Exec. Director of R&D and Exec. Director
    Comp: $119.82k
  • Mr. Rene Kamminga
    CEO of Functional Fibres & Director
  • Mr. Mark Kingsley Collingbourne (Age 57)
    CFO & Sec.
  • Paul Cannings
    Head of Operations & Quality
  • Kevin James Newman
    Corp. Devel. Director
  • Mr. Karl Burkitt
    Marketing Director

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions













OPTI Stock - Frequently Asked Questions

How have OPTI shares performed in 2023?

OptiBiotix Health's stock was trading at GBX 13.25 at the beginning of 2023. Since then, OPTI stock has decreased by 0.9% and is now trading at GBX 13.13.
View the best growth stocks for 2023 here.

How were OptiBiotix Health's earnings last quarter?

OptiBiotix Health Plc (LON:OPTI) issued its quarterly earnings data on Thursday, September, 24th. The company reported ($0.70) earnings per share (EPS) for the quarter.

What other stocks do shareholders of OptiBiotix Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OptiBiotix Health investors own include Digital Globe Services (DGS), Derwent London (DLN), Oracle (ORCL), IQE (IQE), IP Group (IPO), London Stock Exchange Group plc (LSE.L) (LSE), Petrofac (PFC), Motif Bio (MTFB), Yamana Gold (YRI) and Agios Pharmaceuticals (AGIO).

What is OptiBiotix Health's stock symbol?

OptiBiotix Health trades on the London Stock Exchange (LON) under the ticker symbol "OPTI."

How do I buy shares of OptiBiotix Health?

Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is OptiBiotix Health's stock price today?

One share of OPTI stock can currently be purchased for approximately GBX 13.13.

How much money does OptiBiotix Health make?

OptiBiotix Health (LON:OPTI) has a market capitalization of £11.97 million and generates £1.26 million in revenue each year.

How can I contact OptiBiotix Health?

OptiBiotix Health's mailing address is Innovation Centre, Innovation Way, HESLINGTON, YO10 5DG, United Kingdom. The official website for the company is www.optibiotix.com. The company can be reached via phone at +44-20-79338780.

This page (LON:OPTI) was last updated on 1/30/2023 by MarketBeat.com Staff